Historical salary details - Mr. Michael G. Raab, Chairman of the Board, Tempest Therapeutics Inc
Mr. Michael G. Raab is the Chairman of the Board of Tempest Therapeutics Inc. They also hold 2 other positions in Ardelyx Inc and Amicus Therapeutics Inc.
Mr. Michael G. Raab
Chairman of the Board
-
Gross Remuneration
-
Current Company
Tempest Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Tempest Therapeutics Inc | Chairman of the Board | - | - |
| 2024 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2024 | Amicus Therapeutics Inc | Independent Director | - | - |
| 2023 | Amicus Therapeutics Inc | Lead Independent Director and Chairman of the Boar | 426.3 K | 0.3 % |
| 2023 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2022 | Amicus Therapeutics Inc | Lead Independent Director | 425 K | -0.8 % |
| 2022 | Tempest Therapeutics Inc | Chairman of the Board | 96.5 K | -27.9 % |
| 2022 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2021 | Amicus Therapeutics Inc | Lead Independent Director | 428.3 K | 30.4 % |
| 2021 | Tempest Therapeutics Inc | Chairman of the Board | 133.9 K | - |
| 2021 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2020 | Amicus Therapeutics Inc | Lead Independent Director | 328.4 K | 2.2 % |
| 2020 | Tempest Therapeutics Inc | Director | - | - |
| 2020 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2019 | Amicus Therapeutics Inc | Lead Independent Director | 321.3 K | 47.7 % |
| 2019 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2018 | Amicus Therapeutics Inc | Lead Independent Director | 217.5 K | 6.1 % |
| 2018 | Ardelyx Inc | Director, President and Chief Executive Officer | - | - |
| 2017 | Amicus Therapeutics Inc | Independent Director | 205.0 K | 39.6 % |
| 2017 | Ardelyx Inc | President, Chief Executive Officer and Director | - | - |
| 2016 | Amicus Therapeutics Inc | Independent Director | 146.9 K | -35.4 % |
| 2016 | Ardelyx Inc | President, Chief Executive Officer and Director | - | - |
| 2015 | Amicus Therapeutics Inc | Independent Director | 227.5 K | 204.3 % |
| 2015 | Ardelyx Inc | President, Chief Executive Officer and Director | - | - |
| 2014 | Amicus Therapeutics Inc | Independent Director | 74.8 K | -6.9 % |
| 2014 | Ardelyx Inc | President, Chief Executive Officer and Director | - | - |
| 2013 | Amicus Therapeutics Inc | Independent Director | 80.3 K | -14.1 % |
| 2013 | Ardelyx Inc | President, Chief Executive Officer and Director | - | - |
| 2012 | Amicus Therapeutics Inc | Independent Director | 93.4 K | 7.2 % |
| 2011 | Amicus Therapeutics Inc | Independent Director | 87.1 K | 58.9 % |
| 2010 | Amicus Therapeutics Inc | Independent Director | 54.8 K | -40.1 % |
| 2009 | Amicus Therapeutics Inc | Director | 91.5 K | -12.4 % |
| 2008 | Amicus Therapeutics Inc | Director | 104.4 K | 496.8 % |
| 2007 | Amicus Therapeutics Inc | Director | 17.5 K | 100.0 % |
| 2006 | Amicus Therapeutics Inc | Director | 8.8 K | - |